What is the initial treatment approach for chronic headache with a normal MRI Brain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Chronic Headache with Normal MRI Brain

For chronic headache with normal brain MRI, initiate prophylactic therapy with topiramate as first-line treatment while simultaneously addressing medication overuse and implementing behavioral interventions. 1

Initial Clinical Assessment

Once secondary causes are excluded by normal MRI, establish the specific primary headache diagnosis:

  • Confirm chronic headache criteria: Headache occurring ≥15 days per month for at least 3 months 1, 2
  • Assess for medication overuse headache (MOH): Present in up to 73% of chronic migraine patients 1
    • Simple analgesics/NSAIDs used ≥15 days per month indicates overuse 1
    • Triptans used ≥10 days per month indicates overuse 1
  • Have patients maintain a headache diary: Track frequency, severity, triggers, and medication use 1
    • Specifically ask: "Do you feel like you have a headache of some type on 15 or more days per month?" as patients often underreport milder headaches 1

Pharmacologic Management Algorithm

First-Line Prophylactic Treatment

Topiramate is the recommended first-line prophylactic medication, supported by strong evidence from randomized, placebo-controlled trials specifically for chronic migraine 1, 2:

  • Start prophylactic treatment in all patients with chronic headache to reduce frequency and severity 1
  • Maintain for at least 3-6 months before considering discontinuation 1
  • Consider discontinuing after 3-6 months of stability to determine if prophylaxis is still needed 3

Alternative Prophylactic Options

When topiramate is contraindicated or ineffective, consider these alternatives with varying evidence levels 1, 2:

  • OnabotulinumtoxinA (Botox): FDA-approved specifically for chronic migraine prevention (≥15 headache days per month) 4, 5
  • CGRP monoclonal antibodies: Erenumab, fremanezumab, galcanezumab 1
  • Other options: Valproate, gabapentin, amitriptyline, propranolol 1, 2

Important consideration: Select prophylactic medications that may benefit comorbid conditions (e.g., topiramate for patients with obesity; avoid beta-blockers in patients with asthma, diabetes, or bradycardia) 1

Acute Treatment Management

Critical pitfall: Limit acute medication use to prevent medication overuse headache 1:

  • Simple analgesics: <15 days per month 1
  • Triptans: <10 days per month 1

For acute episodes when needed:

  • Stratified-care approach is superior to step-care: Assign treatment based on severity of migraine-related disability 6
    • Mild-moderate attacks: NSAIDs (ibuprofen, naproxen, aspirin) or acetaminophen 7
    • Moderate-severe attacks with disability: Combination of triptan + NSAID (most effective based on recent evidence) 6

Management of Medication Overuse Headache

If medication overuse is identified (present in up to 73% of chronic migraine patients) 1:

  1. Withdraw overused medications 1
    • Abrupt withdrawal is preferred except for opioids 1
  2. Educate patients about the risk of MOH with frequent acute medication use 1
  3. Initiate prophylactic therapy concurrently with medication withdrawal 1

Non-Pharmacological Management

Behavioral interventions should be implemented alongside pharmacologic treatment 1:

  • Evidence-based behavioral therapies: Cognitive behavioral therapy (CBT), relaxation training, thermal biofeedback combined with relaxation, electromyographic biofeedback 6, 1, 2
  • Regular exercise: 40 minutes three times weekly has efficacy comparable to relaxation therapy or topiramate 1, 3
  • Additional modalities with mixed evidence: Acupuncture, progressive muscle relaxation, visualization/guided imagery 6, 1

Address Modifiable Risk Factors and Comorbidities

Screen for and manage common comorbidities 1:

  • Anxiety and depression 1
  • Sleep disorders (including obstructive sleep apnea) 1
  • Obesity 1
  • Caffeine overuse 1
  • Stress 1

Follow-Up and Monitoring

Establish regular follow-up to assess treatment response 1:

  • Use disability assessment tools (e.g., Headache Impact Test [HIT-6]) to monitor progress 3
  • Set realistic expectations: Chronic headache requires long-term management with periods of relapse and remission 1
  • Adjust therapy based on response and tolerability 3
  • Refer to headache specialists when diagnosis is uncertain, treatment is ineffective, or complex comorbidities are present 1

Common Pitfalls to Avoid

  • Underreporting of headache frequency: Patients often fail to report milder headaches; use specific questioning 1
  • Delayed recognition of medication overuse: Screen at every visit as it affects up to 73% of chronic migraine patients 1
  • Premature discontinuation of prophylactic therapy: Benefits may take several weeks to become apparent; maintain for 3-6 months minimum 1, 3
  • Failure to address comorbidities: Untreated psychiatric conditions, sleep disorders, and obesity perpetuate chronic headache 1

References

Guideline

Management of Chronic Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chronic daily headache: diagnosis and management.

American family physician, 2014

Guideline

Management of Abdominal Migraine in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.